Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.
No Thumbnail Available
All Authors
de Tute, RM.
Cook, G.
Cairns, DA.
Brown, JM.
Cavenagh, J.
Ashcroft, AJ.
Snowden, JA.
Yong, K.
Tholouli, E.
Jenner, M.
LTHT Author
de Tute, Ruth
Rawstron, Andy
Owen, Roger
Rawstron, Andy
Owen, Roger
LTHT Department
Haematological Malignancy Diagnostic Service
Leeds Cancer Centre
Haematology
Leeds Cancer Centre
Haematology
Non Medic
Clinical Scientist
Clinical Scientist
Clinical Scientist
Publication Date
2024
Item Type
Letter
Research Support, Non-U.S. Gov't
Research Support, Non-U.S. Gov't
Language
Subject
Subject Headings
Abstract
Journal
Bone Marrow Transplantation